Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Combined immunization using DNA-Sm 14 and DNA-Hsp65 increases CD8+ memory T cells reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection (2014)

  • Authors:
  • USP affiliated authors: FRANTZ, FABIANI GAI - FCFRP ; RODRIGUES, VANDERLEI - FMRP ; RAMOS, SIMONE GUSMÃO - FMRP ; SILVA, CELIO LOPES - FMRP ; FACCIOLI, LUCIA HELENA - FCFRP
  • USP Schools: FCFRP; FMRP; FMRP; FMRP; FCFRP
  • DOI: 10.1186/1471-2334-14-263
  • Subjects: SCHISTOSOMA MANSONI; VACINAÇÃO (MÉTODOS); PROTEÍNAS DE TRANSPORTE; LINFÓCITOS T
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/1471-2334-14-263 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: bronze
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1186/1471-2334-14-263 (Fonte: Unpaywall API)

    Título do periódico: BMC Infectious Diseases

    ISSN: 1471-2334

    • Melhor URL em Acesso Aberto:


    • Outras alternativas de URLs em Acesso Aberto:


        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher




        • Página do artigo
        • Link para o PDF
        • Evidência: oa repository (via OAI-PMH title and first author match)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


        • Página do artigo
        • Evidência: oa repository (via pmcid lookup)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: BMC Infectious Diseases

    ISSN: 1471-2334

    Citescore - 2017: 2.86

    SJR - 2017: 1.576

    SNIP - 2017: 1.187


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2692032pcd 2692032 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ESPÍNDOLA, Milena Sobral; FRANTZ, Fabiani Gai; SOARES, Luana Silva; et al. Combined immunization using DNA-Sm 14 and DNA-Hsp65 increases CD8+ memory T cells reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection. BMC Infectious Diseases, London, v. 14, 2014. Disponível em: < http://dx.doi.org/10.1186/1471-2334-14-263 > DOI: 10.1186/1471-2334-14-263.
    • APA

      Espíndola, M. S., Frantz, F. G., Soares, L. S., Masson, A. P., Tefé-Silva, C., Bitencourt, C. S., et al. (2014). Combined immunization using DNA-Sm 14 and DNA-Hsp65 increases CD8+ memory T cells reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection. BMC Infectious Diseases, 14. doi:10.1186/1471-2334-14-263
    • NLM

      Espíndola MS, Frantz FG, Soares LS, Masson AP, Tefé-Silva C, Bitencourt CS, Oliveira SC, Rodrigues V, Ramos SG, Silva CL, Faccioli LH. Combined immunization using DNA-Sm 14 and DNA-Hsp65 increases CD8+ memory T cells reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection [Internet]. BMC Infectious Diseases. 2014 ; 14Available from: http://dx.doi.org/10.1186/1471-2334-14-263
    • Vancouver

      Espíndola MS, Frantz FG, Soares LS, Masson AP, Tefé-Silva C, Bitencourt CS, Oliveira SC, Rodrigues V, Ramos SG, Silva CL, Faccioli LH. Combined immunization using DNA-Sm 14 and DNA-Hsp65 increases CD8+ memory T cells reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection [Internet]. BMC Infectious Diseases. 2014 ; 14Available from: http://dx.doi.org/10.1186/1471-2334-14-263

    Referências citadas na obra
    WHO: Neglected tropical diseases, hidden successes. 2006, [ http://whqlibdoc.who.int/hq/2006/WHO_CDS_NTD_2006.2_eng.pdf ] Accessed: April 12, 2014
    King CH: Toward the elimination of schistosomiasis. New Engl J Med. 2009, 360 (2): 106-109. 10.1056/NEJMp0808041.
    WHO: Schistosomiasis. 2014, [ http://www.who.int/mediacentre/factsheets/fs115/en/ ] In: N°115 Fs, editor. Accessed: May 01, 2014
    Cioli D: Praziquantel: is there real resistance and are there alternatives?. Curr Opin Infect Dis. 2000, 13 (6): 659-663. 10.1097/00001432-200012000-00014.
    Wang W, Wang L, Liang YS: Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res. 2012, 111 (5): 1871-1877. 10.1007/s00436-012-3151-z.
    Fonseca CT, Brito CF, Alves JB, Oliveira SC: IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine. 2004, 22 (3–4): 503-510.
    Ramos CR, Vilar MM, Nascimento AL, Ho PL, Thaumaturgo N, Edelenyi R, Almeida M, Dias WO, Diogo CM, Tendler M: r-Sm14 - pRSETA efficacy in experimental animals. Memorias do Instituto Oswaldo Cruz. 2001, 96 (Suppl): 131-135.
    Tendler M, Brito CA, Vilar MM, Serra-Freire N, Diogo CM, Almeida MS, Delbem AC, Da Silva JF, Savino W, Garratt RC, Katz N, Simpson AS: A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci U S A. 1996, 93 (1): 269-273. 10.1073/pnas.93.1.269.
    Varaldo PB, Leite LC, Dias WO, Miyaji EN, Torres FI, Gebara VC, Armoa GR, Campos AS, Matos DC, Winter N, Gicquel B, Vilar MM, McFadden J, Almeida MS, Tendler M, McIntosh D: Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge. Infect Immun. 2004, 72 (6): 3336-3343. 10.1128/IAI.72.6.3336-3343.2004.
    Kano FS, Vidotto O, Vidotto MC: DNA vaccines: general concerns and its applications in human and veterinary medicine/Vacina de DNA: aspectos gerais e sua aplicação na medicina humana e veterinária. Semina: Ciências Agrárias. 2007, 28 (4): 709-716.
    Ahmad G, Zhang W, Torben W, Damian RT, Wolf RF, White GL, Chavez-Suarez M, Kennedy RC, Siddiqui AA: Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine. 2009, 27 (21): 2830-2837. 10.1016/j.vaccine.2009.02.096.
    Ahmad G, Zhang W, Torben W, Haskins C, Diggs S, Noor Z, Le L, Siddiqui AA: Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitology research. 2009, 105 (6): 1767-1777. 10.1007/s00436-009-1646-z.
    Da'dara AA, Skelly PJ, Wang MM, Harn DA: Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine. 2001, 20 (3–4): 359-369.
    Shalaby KA, Yin L, Thakur A, Christen L, Niles EG, LoVerde PT: Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes. Vaccine. 2003, 22 (1): 130-136. 10.1016/S0264-410X(03)00535-8.
    Romeih MH, Hassan HM, Shousha TS, Saber MA: Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine. Acta Biochim Biophys Sin (Shanghai). 2008, 40 (4): 327-338. 10.1111/j.1745-7270.2008.00404.x.
    Fonseca CT, Pacifico LG, Barsante MM, Rassi T, Cassali GD, Oliveira SC: Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone. Microbes Infect. 2006, 8 (9–10): 2509-2516.
    de Paula L, Silva CL, Carlos D, Matias-Peres C, Sorgi CA, Soares EG, Souza PR, Blades CR, Galleti FC, Bonato VL, Goncalves ED, Silva EV, Faccioli LH: Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs. Genet Vaccines Ther. 2007, 5: 2-10.1186/1479-0556-5-2.
    Rosada RS, de la Torre LG, Frantz FG, Trombone AP, Zarate-Blades CR, Fonseca DM, Souza PR, Brandao IT, Masson AP, Soares EG, Ramos SG, Faccioli LH, Silva CL, Santana MH, Coelho-Castelo AA: Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol. 2008, 9: 38-10.1186/1471-2172-9-38.
    Silva CL, Bonato VL, Coelho-Castelo AA, De Souza AO, Santos SA, Lima KM, Faccioli LH, Rodrigues JM: Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Ther. 2005, 12 (3): 281-287. 10.1038/sj.gt.3302418.
    Coelho EA, Tavares CA, Lima Kde M, Silva CL, Rodrigues JM, Fernandes AP: Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection. Parasitol Res. 2006, 98 (6): 568-575. 10.1007/s00436-005-0088-5. Epub 2006 Jan 2024
    Ribeiro AM, Bocca AL, Amaral AC, Faccioli LH, Galetti FC, Zarate-Blades CR, Figueiredo F, Silva CL, Felipe MS: DNAhsp65 vaccination induces protection in mice against Paracoccidioides brasiliensis infection. Vaccine. 2009, 27 (4): 606-613. 10.1016/j.vaccine.2008.10.022.
    Siqueira IM, Ribeiro AM, Nobrega YK, Simon KS, Souza AC, Jeronimo MS, Cavalcante Neto FF, Silva CL, Felipe MS, Bocca AL: DNA-hsp65 vaccine as therapeutic strategy to treat experimental chromoblastomycosis caused by Fonsecaea pedrosoi. Mycopathologia. 2013, 175 (5–6): 463-475.
    Santos Junior RR, Sartori A, Bonato VL, Coelho Castelo AA, Vilella CA, Zollner RL, Silva CL: Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression. Clin Exp Immunol. 2007, 149 (3): 570-578. 10.1111/j.1365-2249.2007.03433.x.
    Santos-Junior RR, Sartori A, De Franco M, Filho OG, Coelho-Castelo AA, Bonato VL, Cabrera WH, Ibanez OM, Silva CL: Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis. Hum Gene Ther. 2005, 16 (11): 1338-1345. 10.1089/hum.2005.16.1338.
    Fonseca DM, Wowk PF, Paula MO, Campos LW, Gembre AF, Turato WM, Ramos SG, Dias-Baruffi M, Barboza R, Gomes E, Silva CL, Russo M, Bonato VL: Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway. Clin Exp Allergy. 2012, 42 (1): 131-143. 10.1111/j.1365-2222.2011.03845.x.
    Michaluart P, Abdallah KA, Lima FD, Smith R, Moyses RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zarate-Blades CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL: Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Ther. 2008, 15 (10): 676-684. 10.1038/cgt.2008.35.
    Victora GD, Socorro-Silva A, Volsi EC, Abdallah K, Lima FD, Smith RB, Moyses RA, Zarate-Blades CR, Michaluart P, Silva CL, Kalil J, Coelho V: Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients. Cancer Gene Ther. 2009, 16 (7): 598-608. 10.1038/cgt.2009.9.
    Frantz FG, Ito T, Cavassani KA, Hogaboam CM, Lopes Silva C, Kunkel SL, Faccioli LH: Therapeutic DNA vaccine reduces Schistosoma mansoni-induced tissue damage through cytokine balance and decreased migration of myofibroblasts. Am J Pathol. 2011, 179 (1): 223-229. 10.1016/j.ajpath.2011.03.012.
    Pellegrino J, Siqueira AF: A perfusion technic for recovery of Schistosoma mansoni from experimentally infected guinea pigs. Rev Bras Malariol Doencas Trop. 1956, 8 (4): 589-597.
    Pellegrino J, Faria J: The oogram method for the screening of drugs in schistosomiasis mansoni. Am J Trop Med Hyg. 1965, 14: 363-369.
    Pellegrino J, Katz N: Experimental chemotherapy of schistosomiasis. IV. Oogram studies with nicarbazin, an egg-suppressive agent. Rev Inst Med Trop Sao Paulo. 1969, 11 (3): 215-221.
    Bitencourt CS, Pereira PA, Ramos SG, Sampaio SV, Arantes EC, Aronoff DM, Faccioli LH: Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis. Fibrogenesis Tissue Repair. 2011, 4 (1): 3-10.1186/1755-1536-4-3.
    Ito T, Schaller M, Hogaboam CM, Standiford TJ, Chensue SW, Kunkel SL: TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response. Eur J Immunol. 2007, 37 (10): 2847-2855. 10.1002/eji.200737603.
    Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, McManus DP: Immunopathogenesis of human schistosomiasis. Parasite Immunol. 2009, 31 (4): 163-176. 10.1111/j.1365-3024.2009.01098.x.
    Carvalho JA, Rodgers J, Atouguia J, Prazeres DM, Monteiro GA: DNA vaccines: a rational design against parasitic diseases. Expert Rev Vaccines. 2010, 9 (2): 175-191. 10.1586/erv.09.158.
    Laddy DJ, Weiner DB: From plasmids to protection: a review of DNA vaccines against infectious diseases. Int Rev Immunol. 2006, 25 (3–4): 99-123.
    Anand SB, Murugan V, Prabhu PR, Anandharaman V, Reddy MV, Kaliraj P: Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. Acta tropica. 2008, 107 (2): 106-112. 10.1016/j.actatropica.2008.04.018.
    Ahmed SB, Touihri L, Chtourou Y, Dellagi K, Bahloul C: DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice. Vaccine. 2009, 27 (1): 99-106. 10.1016/j.vaccine.2008.10.013.
    Almeida LP, Trombone AP, Lorenzi JC, Rocha CD, Malardo T, Fontoura IC, Gembre AF, Silva RL, Silva CL, Castelo AP, Coelho-Castelo AA: B cells can modulate the CD8 memory T cell after DNA vaccination against experimental tuberculosis. Genet Vaccines Ther. 2011, 9: 5-10.1186/1479-0556-9-5.
    Palliser D, Huang Q, Hacohen N, Lamontagne SP, Guillen E, Young RA, Eisen HN: A role for Toll-like receptor 4 in dendritic cell activation and cytolytic CD8+ T cell differentiation in response to a recombinant heat shock fusion protein. J Immunol. 2004, 172 (5): 2885-2893. 10.4049/jimmunol.172.5.2885.
    Garcia TC, Fonseca CT, Pacifico LG, Duraes Fdo V, Marinho FA, Penido ML, Caliari MV, de Melo AL, Pinto HA, Barsante MM, Cunha-Neto E, Oliveira SC: Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice. Acta tropica. 2008, 106 (3): 162-167. 10.1016/j.actatropica.2008.03.003.